DD151059A5 - Neue peptide und verfahren zu ihrer herstellung - Google Patents

Neue peptide und verfahren zu ihrer herstellung Download PDF

Info

Publication number
DD151059A5
DD151059A5 DD80219646A DD21964680A DD151059A5 DD 151059 A5 DD151059 A5 DD 151059A5 DD 80219646 A DD80219646 A DD 80219646A DD 21964680 A DD21964680 A DD 21964680A DD 151059 A5 DD151059 A5 DD 151059A5
Authority
DD
German Democratic Republic
Prior art keywords
phe
trp
thr
lys
solution
Prior art date
Application number
DD80219646A
Other languages
German (de)
English (en)
Inventor
Bruno Kamber
Hans Rink
Peter Sieber
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of DD151059A5 publication Critical patent/DD151059A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/655Somatostatins
    • C07K14/6555Somatostatins at least 1 amino acid in D-form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/02Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/06General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
    • C07K1/061General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups
    • C07K1/065General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups for hydroxy functions, not being part of carboxy functions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/16Somatostatin; related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DD80219646A 1979-03-16 1980-03-13 Neue peptide und verfahren zu ihrer herstellung DD151059A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH250679 1979-03-16

Publications (1)

Publication Number Publication Date
DD151059A5 true DD151059A5 (de) 1981-09-30

Family

ID=4235326

Family Applications (1)

Application Number Title Priority Date Filing Date
DD80219646A DD151059A5 (de) 1979-03-16 1980-03-13 Neue peptide und verfahren zu ihrer herstellung

Country Status (17)

Country Link
US (1) US4316890A (fr)
EP (1) EP0017760B1 (fr)
JP (1) JPS55124748A (fr)
KR (1) KR830001872A (fr)
AT (1) ATE3283T1 (fr)
AU (1) AU5646280A (fr)
CA (1) CA1140117A (fr)
DD (1) DD151059A5 (fr)
DE (1) DE3063028D1 (fr)
ES (1) ES489565A0 (fr)
FI (1) FI800795A (fr)
GR (1) GR67655B (fr)
IL (1) IL59620A (fr)
NO (1) NO800743L (fr)
NZ (1) NZ193129A (fr)
PT (1) PT70951A (fr)
ZA (1) ZA801520B (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4499079A (en) * 1982-11-18 1985-02-12 E. R. Squibb & Sons, Inc. Carboxy and substituted carboxy alkanoyl and cycloalkanoyl peptides
US4612302A (en) * 1983-11-14 1986-09-16 Brigham And Women's Hospital Clinical use of somatostatin analogues
US5504069A (en) * 1993-02-11 1996-04-02 Biomeasure, Inc. Inhibition of trauma-induced tumor growth
US5965698A (en) * 1993-04-23 1999-10-12 Virginia Commonwealth University Polypeptides that include conformation-constraining groups which flank a protein--protein interaction site
US5928896A (en) * 1993-04-23 1999-07-27 Virginia Commonwealth University Polypeptides that include conformation-constraining groups which flank a protein--protein interaction site
US5952465A (en) * 1993-04-23 1999-09-14 Virginia Commonwealth University Polypeptides that include conformation-constraining groups which flank a protein-protein interaction site
WO1994025482A1 (fr) * 1993-04-23 1994-11-10 Evans Herbert J Polypeptides comprenant des groupes contraignant la conformation qui sont adjacents a un site d'interaction proteine-proteine
US6258550B1 (en) 1993-04-23 2001-07-10 Virginia Commonwealth University Polypeptides that include conformation-constraining groups which flank a protein-protein interaction site
US6084066A (en) * 1993-10-29 2000-07-04 Virginia Commonwealth University Polypetides that include conformation-constraining groups which flank a protein-protein interaction site
US5597894A (en) * 1995-06-05 1997-01-28 The Louisiana State University Medical Center Foundation Multi-tyrosinated somatostatin analogs
EP0981364B1 (fr) * 1997-05-13 2006-03-01 Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. Procede et compositions pour traiter l'hyperlipidemie
US6004928A (en) * 1997-05-13 1999-12-21 Biomeasure, Incorporated Method of treating hyperlipidemia
ES2216290T3 (es) * 1997-05-13 2004-10-16 Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. Somatostatina y agonistas de la somatostatina para el tratamiento de insensibilidad a la insulina y de sindrome x.
AU7655098A (en) 1997-05-13 1998-12-08 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) Somatostatin and somatostatin agonists for decreasing body weight
US5968903A (en) * 1998-05-07 1999-10-19 Biomeasure, Incorporated Inhibition of H. pylori proliferation
PT2062914E (pt) 2001-06-08 2014-07-18 Ipsen Pharma Sas Análogos quiméricos de somatostatina-dopamina
EP2161037A3 (fr) 2003-04-22 2010-05-26 Ipsen Pharma Conjugués de Camptothecin-Somatostatin
US20110171191A1 (en) 2008-06-12 2011-07-14 Syntaxin Limited Suppression of neuroendocrine diseases
US10240138B2 (en) 2008-06-12 2019-03-26 Ipsen Bioinnovation Limited Polypeptides that bind to and inhibit secretion from growth hormone secreting cells
GB0820970D0 (en) 2008-11-17 2008-12-24 Syntaxin Ltd Suppression of cancer
JP6869720B2 (ja) 2013-06-13 2021-05-12 アンチセンス セラピューティクス リミテッド 併用療法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4020157A (en) * 1975-07-08 1977-04-26 Ayerst Mckenna And Harrison Ltd. Shortened analogs of somatostatin
US4372884A (en) * 1975-08-06 1983-02-08 The Salk Institute For Biological Studies Pharmaceutically active peptides
NL7607987A (nl) * 1975-08-08 1977-02-10 Merck & Co Inc Werkwijze voor het bereiden van peptiden.
US4122077A (en) * 1976-12-17 1978-10-24 American Home Products Corporation Somatostatin analogs
US4098782A (en) * 1977-03-14 1978-07-04 American Home Products Corporation (His5)-somatostatin and analogues thereof
US4115554A (en) * 1977-08-29 1978-09-19 Merck & Co., Inc. Somatostatin analogs
GB2019411B (en) * 1978-04-24 1982-06-16 American Home Prod Peptides related to somatostatin

Also Published As

Publication number Publication date
NZ193129A (en) 1982-06-29
DE3063028D1 (en) 1983-06-16
IL59620A0 (en) 1980-06-30
CA1140117A (fr) 1983-01-25
ZA801520B (en) 1981-03-25
ES8103028A1 (es) 1981-02-16
FI800795A (fi) 1980-09-17
AU5646280A (en) 1980-09-18
JPS55124748A (en) 1980-09-26
ATE3283T1 (de) 1983-05-15
US4316890A (en) 1982-02-23
NO800743L (no) 1980-09-17
ES489565A0 (es) 1981-02-16
IL59620A (en) 1983-07-31
EP0017760B1 (fr) 1983-05-11
KR830001872A (ko) 1983-05-19
PT70951A (en) 1980-04-01
EP0017760A1 (fr) 1980-10-29
GR67655B (fr) 1981-09-02

Similar Documents

Publication Publication Date Title
EP0023192B1 (fr) Cyclopeptides et compositions pharmaceutiques les contenant ainsi que procédé pour leur préparation et leur utilisation
DD151059A5 (de) Neue peptide und verfahren zu ihrer herstellung
EP0001295B1 (fr) Cyclopeptides analogues à la somatostatine, procédé pour leur préparation, compositions pharmaceutiques les contenant et leur application thérapeutique
EP0030920B1 (fr) Acylpeptides et leurs préparations pharmaceutiques, ainsi que leur préparation et leur application
EP0083305B1 (fr) Octapeptides cycliques, préparations pharmaceutiques les contenant et procédés de leur préparation et leur utilisation
DE3853384T2 (de) Peptid.
EP0031303A2 (fr) Cyclooctapeptides et leurs préparations pharmaceutiques, procédé pour leur préparation et leur application
DE69101187T2 (de) VIP-Analogen und ihre Verwendung.
DD156968A5 (de) Verfahren zur herstellung von neuen angiotensin-ii antagonisierenden oktapeptidestern
CH629475A5 (de) Verfahren zur herstellung von polypeptiden.
DE3326472A1 (de) Neue insulin-derivate, verfahren zu deren herstellung und deren verwendung sowie pharmazeutische mittel zur behandlung des diabetes mellitus
DE3333640A1 (de) Verfahren zur herstellung von insulin-derivaten, deren b-kette c-terminal verlaengert ist, neue basisch modifizierte insulin-derivate diese enthaltende mittel und ihre verwendung
DE69003595T2 (de) Mikroproteine, Verfahren zur Herstellung derselben und Anwendung dieser Mikroproteine als Arzneimittel.
DE69426270T2 (de) Hgh-rh(1-29)nh2 analoge mit antagonistischer aktivität
DE2635558A1 (de) Somatostatinanaloge
DE3875765T2 (de) Fluor enthaltende atriale natriuretische peptide.
DE60218199T2 (de) Humane wachstumshormone freisetzende hormonanaloge, deren herstellung und verwendung
DE2633976A1 (de) Tripeptidderivate, verfahren zu ihrer herstellung sowie diese enthaltende arzneimittel
EP0003028B1 (fr) Analogues de la bêta h-endorphine, préparations les contenant et leur procédé de préparation
DD217808A5 (de) Verfahren zur herstellung von saeugetier-pgrf
DE3883649T2 (de) Therapeutische Analoga von Somatostatin.
DE2423549A1 (de) Verfahren zur herstellung von cystinhaltigen peptiden
DE69032591T2 (de) Physiologisch aktive peptide und den calcium-metabolismus regulierende arzneimittel, die genannte peptide als wirkungsvollen bestandteil enthalten
CH632486A5 (de) Verfahren zur herstellung von tetradecapeptiden.
EP0596350B1 (fr) Cyclopeptides